MedPath

MDK-NITISINONE

MDK-NITISINONE

Approved
DIN Number

02457733

Drug Class

Human

Market Date

Oct 20, 2016

Company
HC

Mendelikabs Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02457733
AIG Number0158450003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A16AX04 NITISINONE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification92:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NITISINONEActive
Strength: 10 MG
Monograph: NITISINONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.